Skip to main content
TipRanks
Go Ultimate75% OFF

Faes Farma (0K9H) AI Stock Analysis

2 Followers
GB:0K9H

Faes Farma

(LSE:0K9H)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Historical Profitability and Equity BaseFaes Farma has demonstrated substantial earnings power over several years, supported by historically high margins and a sizable equity base. This track record provides a foundation for recovery and gives the company greater capacity to sustain operations and invest through periods of weaker performance.
Negative Factors
2025 Revenue and Margin ContractionThe latest reported year shows a meaningful deterioration from the company’s prior growth and profitability profile. Lower revenue and sharply compressed margins can weaken earnings power, reduce funds available for investment, and indicate that restoring sustainable growth may require improved execution.

Faes Farma (0K9H) vs. iShares MSCI United Kingdom ETF (EWC)

-5%0%5%10%15%20%25%GB:0K9H+6.18%EWC+8.99%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.52B
Dividend Yield
2.64%
Average Volume (3M)
26.30K
Price to Earnings (P/E)
11.1
Beta (1Y)
0.54
Revenue Growth
31.88%
EPS Growth
-20.09%
Country
UK
Employees
2,677
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Faes Farma Business Overview & Revenue Model

Company Description

Faes Farma, S.A. is a pharmaceutical enterprise dedicated to the research, development, manufacture, and distribution of both finished medicinal products and crucial raw materials. Its extensive operations span Spain and a multitude of international...

Faes Farma Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

GB:0K9H against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ES:NTHES:NTH81OutperformEUR 127.09M14.3952.07%11.96%-6.06%-15.89%
ES:GRFES:GRF75OutperformEUR 6.61B15.148.83%0.76%1.03%30.59%
ES:LOGES:LOG72OutperformEUR 4.80B17.1343.48%5.78%2.23%0.36%
ES:ALMES:ALM70OutperformEUR 2.22B30.564.81%1.79%9.67%174.00%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
ES:RJFES:RJF47NeutralEUR 215.72M30.933.14%0.74%-0.42%4.56%

* Healthcare Sector Average

Performance Comparison

-20%0%20%GB:0K9HES:ALMES:GRFES:RJFES:LOGES:NTHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0K9H and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0K9HFaes Farma4.830.327.17%
ES:ALMAlmirall SA10.26-2.16-17.36%
ES:GRFGrifols (0RDU)10.900.686.67%
ES:RJFLABORATORIO REIG JOFRE2.62-0.03-1.17%
ES:LOGCompania de Distribucion Integral Logista Holdings36.488.6531.07%
ES:NTHNaturhouse Health2.090.178.74%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.